These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3491486)

  • 1. Carbamazepine effects on mononuclear blood cells in epileptic patients.
    Gilhus NE; Matre R
    Acta Neurol Scand; 1986 Sep; 74(3):181-5. PubMed ID: 3491486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of carbamazepine and valproate on immunological assessment in young epileptic patients.
    Lenti C; Masserini C; Peruzzi C; Guareschi Cazzullo A
    Ital J Neurol Sci; 1991 Feb; 12(1):87-91. PubMed ID: 2013529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic aspects of carbamazepine treatment in epileptic patients.
    Pacifici R; Paris L; Di Carlo S; Pichini S; Zuccaro P
    Epilepsia; 1991; 32(1):122-7. PubMed ID: 1985820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chronic anticonvulsant monotherapy on lymphocyte subpopulations in adult epileptic patients.
    Marcoli M; Gatti G; Ippoliti G; Lombardi M; Crema A; Zocchi MT; De Ponti F; Lecchini S; Frigo GM
    Hum Toxicol; 1985 Mar; 4(2):147-57. PubMed ID: 3874143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte subpopulations and lymphocyte function in phenytoin-treated patients with epilepsy.
    Gilhus NE; Matre R; Aarli JA
    Int J Immunopharmacol; 1982; 4(1):43-8. PubMed ID: 6979523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral and cellular immune parameters in untreated and phenytoin-or carbamazepine-treated epileptic patients.
    Başaran N; Hincal F; Kansu E; Ciğer A
    Int J Immunopharmacol; 1994 Dec; 16(12):1071-7. PubMed ID: 7705969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine production in blood mononuclear cells from epileptic patients.
    Pacifici R; Paris L; Di Carlo S; Bacosi A; Pichini S; Zuccaro P
    Epilepsia; 1995 Apr; 36(4):384-7. PubMed ID: 7607117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of carbamazepine on serum immunoglobulin concentrations.
    Gilhus NE; Strandjord RE; Aarli JA
    Acta Neurol Scand; 1982 Aug; 66(2):172-9. PubMed ID: 7136483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of metabolic parameters of carbamazepine in the therapeutic monitoring of Tunisian patients with epilepsy.
    Chbili C; Hassine A; Ben Amor S; Nouira M; Ben Ammou S; Saguem S
    Rev Neurol (Paris); 2016; 172(4-5):313-7. PubMed ID: 27062293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic effects of phenytoin and/or carbamazepine on human peripheral leukocytes.
    Flejter WL; Astemborski JA; Hassel TM; Cohen MM
    Epilepsia; 1989; 30(3):374-9. PubMed ID: 2721469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum steroid hormones and pituitary function in female epileptic patients during carbamazepine therapy.
    Isojärvi JI
    Epilepsia; 1990; 31(4):438-45. PubMed ID: 2142450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal change glomerulonephritis and focal glomerulosclerosis markers and 'in vitro' activity of peripheral blood mononuclear cell.
    Dall'Aglio P; Chizzolini C; Brigati C
    Proc Eur Dial Transplant Assoc; 1983; 19():673-8. PubMed ID: 6348758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopharmacologic study of blood carbamazepine levels in a group of epileptic patients].
    Testa G; Ermani M; Giaretta D; Pellegrini A; Paleari C
    Riv Neurol; 1980; 50(4):241-52. PubMed ID: 7466220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrophobic sodium fluoride-based nanocrystals doped with lanthanide ions: assessment of in vitro toxicity to human blood lymphocytes and phagocytes.
    Sojka B; Kuricova M; Liskova A; Bartusova M; Banski M; Misiewicz J; Dusinska M; Horvathova M; Jahnova E; Ilavska S; Szabova M; Rollerova E; Podhorodecki A; Tulinska J
    J Appl Toxicol; 2014 Nov; 34(11):1220-5. PubMed ID: 25179008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations of carbamazepine and carbamazepine-10, 11-epoxide in serum, brain tumors and paratumorous cortex: a prospective study of 37 neurosurgically treated epileptic patients.
    Schnabel R; Rambeck B; May TW; Jürgens U; Lahl R
    Eur Neurol; 1994; 34(4):213-20. PubMed ID: 8082680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laser evoked potentials and carbamazepine in epileptic patients.
    Galeotti F; Truini A; Iannetti GD; Romaniello A; Biasiotta A; Mascia A; Virtuoso M; Cruccu G
    Neurophysiol Clin; 2005 Jul; 35(2-3):93-6. PubMed ID: 16087072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vitro effect of phenytoin and carbamazepine on subpopulations of human blood mononuclear cells.
    Gilhus NE
    Int J Immunopharmacol; 1983; 5(4):283-8. PubMed ID: 6605315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary immunoglobulin concentrations in patients with epilepsy treated with carbamazepine.
    Gilhus NE; Strandjord RE; Aarli JA
    Acta Neurol Scand; 1980 Nov; 62(5):300-4. PubMed ID: 7468153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intradose and circadian variation in circulating carbamazepine and its epoxide in epileptic patients: a consequence of autoinduction of metabolism.
    Macphee GJ; Butler E; Brodie MJ
    Epilepsia; 1987; 28(3):286-94. PubMed ID: 3582293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily variations in steady-state plasma concentrations of carbamazepine and its metabolites in epileptic children.
    Hartley R; Forsythe WI; McLain B; Ng PC; Lucock MD
    Clin Pharmacokinet; 1991 Mar; 20(3):237-46. PubMed ID: 2025982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.